Elizabeth J. Carey, Manjushree Gautam, Timothy Ingall, David D. Douglas – 30 January 2008 – Autonomic dysfunction is a recognized complication of end‐stage liver disease (ESLD), but there is little information on how liver transplantation (LT) affects this problem. We sought to prospectively evaluate autonomic function in patients with ESLD before and after LT. Autonomic reflex screen (ARS) was performed on 30 patients with ESLD prior to transplantation. A 10‐point composite autonomic score (CAS) was calculated from these data.

Jose L. del Pozo, Jose Ignacio Herrero, Andrea Manubens, Emilio Garcia‐Quetglas, Jose Ramon Yuste, Matias Alfonso, Jose Leiva, Jorge Quiroga, Jose Ramon Azanza – 30 January 2008

James D. Perkins – 30 January 2008

Sarwa Darwish Murad, Patrick S. Kamath – 30 January 2008

Jacob Alexander, James D. Lord, Matthew M. Yeh, Carlos Cuevas, Ramasamy Bakthavatsalam, Kris V. Kowdley – 30 January 2008 – Orthotopic liver transplantation (OLT) is the only effective treatment for end‐stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC. We performed a retrospective analysis of 69 consecutive patients who underwent a first OLT for PSC over a 14‐year period.

Toru Ikegami, Satoru Imura, Yusuke Arakawa, Mitsuo Shimada – 30 January 2008

Santiago Tome, Adnan Said, Michael R. Lucey – 30 January 2008

Ashokkumar Jain, Rajeev Sharma, Charlotte Ryan, Georgious Tsoulfas, Mark Orloff, Peter Abt, Randeep Kashyap, Pam Batzold, Lisa Sauberman, Saman Safadjou, Maureen Graham, Adel Bozorgzadeh – 30 January 2008 – With the current immunosuppressive regimens, graft loss secondary to immunological reasons after successful liver transplantation is a rarity; acute rejections, however, do occur, with the majority of them being steroid‐responsive.

Evangelos Cholongitas, Vibhakorn Shusang, George V. Papatheodoridis, Laura Marelli, Pinelopi Manousou, Nancy Rolando, David Patch, Keith Rolles, Brian Davidson, Andrew K. Burroughs – 30 January 2008 – Liver transplantation (LT) is the only therapeutic option for end‐stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation for PSC (42 male, mean age 41.9 yr).

Mazen Alsatie, Prashant Pandya, Naga P. Chalasani – 30 January 2008